About
CardiaCare is a clinical-stage Digital Therapeutic company focused on developing a closed-loop wearable device for the non-invasive treatment of cardiac and central nervous system-related symptoms, particularly atrial fibrillation (AF). Their innovative technology combines neuromodulation therapy with continuous remote cardiac monitoring, utilizing AI-driven personalized treatment and machine learning algorithms. The company's wrist-worn device delivers electrical stimulation to the median and ulnar nerves, indirectly modulating the vagus nerve to help manage heart rate and blood pressure. It features a closed-loop monitoring system with optical and ECG sensors that collect cardiac data, which is analyzed through a proprietary cloud platform. This system provides real-time ECG tracking, arrhythmia alerts, and personalized insights for both patients and healthcare providers, enhancing the management of AF symptoms and improving overall cardiovascular health. CardiaCare's approach supports patients seeking home-based management of AF, as well as healthcare providers looking for effective remote monitoring tools. The company has established a strategic partnership with Dr. Reddy’s Laboratories and has been recognized as a 2022 MedTech Innovator cohort company, highlighting its commitment to advancing AF care through innovative technology.
Technologies
Keywords
Company Information
-
Employees 10
-
Founded 2015
Location
2 ספיר, Ness Ziona, Center District, Israel, 74000
